Lipitor Lawsuit Filings Go From 56 to 1,000 in Five Months, Reuters Review Finds

Published on August 19, 2014 by Sandy Liebhard

Text-Size:A A A+


Women are coming forward in droves to file Lipitor lawsuit filings against Pfizer, Inc, according to a recent Reuters review of federal court filings.

An Associated Press article on August 8th indicates that cases against Pfizer Inc. have increased from 56 to nearly 1,000 in the past five months, following the centralization of similar lawsuits in the U.S. District Court, District of South Carolina. There, a multidistrict litigation (MDL) now includes at least 1,162 claims over the medication, according to a federal Case List updated on August 15th. Lawsuits in the District of South Carolina were filed after a February 2012 mandate from the U.S. Food and Drug Administration (FDA) that all statin manufacturers include the risk for new-onset Type 2 diabetes on their labeling. A month earlier, a study published in JAMA: Internal Medicine revealed that women taking this type of cholesterol-lowering drug may be at an increased risk of developing the disease. At the time, some FDA officials defended the safety of Lipitor and other statins. “Clearly, we think that the heart benefit of statins outweighs this small increased risk (for diabetes),” says Amy Egan, a deputy director for safety at the U.S. regulator’s Division of Metabolism and Endocrinology.

Pfizer Denies Liability in Lipitor Diabetes Suits

Pfizer said in a recent statement that it denies liability in lawsuits alleging Lipitor diabetes complications, and is prepared to defend claims that accuse the company of withholding vital safety information from the public. reports that Lipitor is the best-selling prescription drug in history, garnering more than $130 billion in sales since 1996, when it entered the market. Almost 30 million patients in the U.S. have been prescribed the cholesterol medication, which the article suggests may ignite more lawsuit filings.

Claims that have already been filed over Lipitor are continuing to move forward in the District of South Carolina, court records indicate. The first hearing in the federal litigation’s bellwether trial program is scheduled to take place in July 2015, the outcome of which may indicate how future juries will rule in actions over the statin, FoxNews reports.

Contact a Lipitor Lawyer Today

If you or a woman you love developed Type 2 diabetes after taking Lipitor, the time is now to take action against Pfizer. Call our Firm today at .